Clinical Efficacy and Meta-Analysis of Stem Cell Therapies for Patients with Brain Ischemia

Table 4

The correlations of Barthel and clinical variables across studies by subgroup and heterogeneity analysis.

Subgroup	Mean difference (95% CI)	(%)
Patients’ characteristics
Acute stoke	12.61 (2.39, 22.84)	84
Chronic stroke	7.19 (4.18, 10.20)	0
Cell type
MSC	8.37 (4.83, 11.91)	63
Non-MSC	—	—
Route of delivery
Intravenous injection	7.58 (3.85, 11.30)	30
Non-IV	12.56 (−3.16, 28.27)	91
Follow-up period
<6 months	5.2 (4.06, 6.34)	—
6 months	9.52 (4.92, 14.13)	58